All About You Medspa, LLC – FDA Warning Letter

The FDA issued a Warning Letter to Ms. Deborah A. West of All About You Med Spa, citing false or misleading claims on her website, www.allaboutyoumedispa.com, regarding Lipodissolve products. As of November 30, 2009, these products were deemed misbranded under the Federal Food, Drug, and Cosmetic Act (FDCA), specifically 21 U.S.C. §§ 352(a), 352(n), and 321(n), and FDA regulations 21 CFR 202.1(e)(5)(i) and (e)(6)(i). The FDA classified Lipodissolve products as drugs (21 U.S.C. § 321(g)(1)) due to their intended use to treat disease or affect body function, with injectable versions further classified as prescription drugs (21 U.S.C. § 353(b)(1)) requiring professional supervision. The misbranding resulted from unsubstantiated efficacy claims, such as those related to fat reduction and evenness, and unsubstantiated safety claims, including references to clinical trials and a lack of adverse effects. The FDA stated it is unaware of evidence supporting these claims. The firm must take prompt corrective action, investigate root causes, and prevent recurrence. A written response detailing corrective steps and supporting documentation is required within fifteen working days. Failure to comply may lead to legal actions like seizure or injunction and could impact future federal contracts.